US phases out South Africa HIV aid
Analysis based on 17 articles · First reported Jun 12, 2026 · Last updated Jun 24, 2026
The withdrawal of over $400 million in annual U.S. foreign aid to South Africa, particularly through PEPFAR, is expected to severely impact the healthcare sector in South Africa, especially HIV prevention and treatment programs. This could lead to increased health crises and social instability, potentially affecting investor confidence in South Africa's economy. Companies like Anova Health Institute are already experiencing significant operational disruptions and job losses.
The United States, under the Trump administration, is phasing out over $400 million in annual support for South Africa's HIV programs through the United States — President s Emergency Plan for AIDS Relief (PEPFAR). This decision, announced in January 2025, stems from political issues cited by Donald Trump, including South Africa's Black Economic Empowerment policies, land expropriation laws, and its condemnation of Israel's actions in Gaza at the International Court of Justice. The United States — United States Department of State also required South African officials to condemn the 'Kill the Boer' song. The withdrawal of funds, which constitutes about 17% of South Africa's HIV budget, has led to the closure of support facilities, job losses for front-line health workers, and a significant impact on prevention services, as highlighted by civil society groups like Section27 and the Anova Health Institute. South Africa has initiated a $45 million emergency fund to mitigate the impact.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard